Basepoint Wealth’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$269K Sell
3,571
-2,121
-37% -$151K 0.15% 85
2025
Q4
$352K Sell
5,692
-3,020
-35% -$178K 0.21% 63
2025
Q3
$512K Sell
8,712
-2,241
-20% -$131K 0.36% 53
2025
Q2
$637K Sell
10,953
-2,372
-18% -$134K 0.49% 41
2025
Q1
$661K Sell
13,325
-734
-5% -$37.6K 0.52% 43
2024
Q4
$629K Sell
14,059
-330
-2% -$15.7K 0.5% 50
2024
Q3
$692K Sell
14,389
-280
-2% -$13.5K 0.51% 45
2024
Q2
$747K Sell
14,669
-245
-2% -$13.4K 0.59% 41
2024
Q1
$810K Buy
14,914
+88
+0.6% +$4.59K 0.61% 39
2023
Q4
$835K Sell
14,826
-581
-4% -$32.8K 0.67% 37
2023
Q3
$952K Buy
15,407
+2,045
+15% +$129K 0.78% 32
2023
Q2
$789K Buy
13,362
+1,023
+8% +$65.1K 0.65% 42
2023
Q1
$911K Buy
12,339
+1,528
+14% +$118K 0.76% 34
2022
Q4
$790K Buy
10,811
+1,295
+14% +$102K 0.7% 38
2022
Q3
$793K Buy
9,516
+462
+5% +$39.7K 0.85% 27
2022
Q2
$722K Buy
9,054
+6,174
+214% +$599K 0.75% 32
2022
Q1
$299K Buy
+2,880
New +$239K 0.28% 60

Other funds holding NTR

Basepoint Wealth's NTR Position: Q1 2026 in Review

Basepoint Wealth reduced its Nutrien (NTR) stake by 37% in Q1 2026, selling an estimated $151K and leaving 3,571 shares worth $269K. The position accounts for 0.15% of the portfolio, ranked #85.

Basepoint Wealth first reported a position in NTR in Q1 2022 and has held it in 17 quarters since. The position peaked at $952K in Q3 2023. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.

  • Basepoint Wealth held 3,571 shares of Nutrien worth $269K as of Q1 2026.
  • Basepoint Wealth sold 2,121 Nutrien shares in Q1 2026, an estimated $151K.
  • Nutrien made up 0.15% of Basepoint Wealth's portfolio in Q1 2026, its #85 holding.
  • Basepoint Wealth first reported a position in Nutrien in Q1 2022 and has held it in 17 quarters since.
  • Basepoint Wealth's Nutrien position peaked at $952K in Q3 2023.
  • 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.

Based on Basepoint Wealth's 13F filing for Q1 2026, filed 7 May 2026.